Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952313 · ClinicalTrials.gov registry record · NA
Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study
A NA study, sponsored by Spirox.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT02952313 is a NA study that has completed, run by Spirox. The registered enrollment target is 113 participants.
The verdict
NCT02952313, a NA study, has completed, sponsored by Spirox.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
This study is being conducted to obtain outcomes data in subjects with severe to extreme class NOSE scores undergoing placement of the Spirox Latera Implant with or without concurrent septoplasty and/or turbinate reduction procedures in an operating room setting.
Interventions
- DEVICE Nasal Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02952313
The ClinicalTrials.gov registry entry for NCT02952313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spirox, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal Implant is the first listed.
NCT02952313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02952313 about?
NCT02952313 is a clinical study titled "Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study". This study is being conducted to obtain outcomes data in subjects with severe to extreme class NOSE scores undergoing placement of the Spirox Latera Implant with or without concurrent septoplasty and/or turbinate reduction procedures in an operating room setting.
What is the current status of trial NCT02952313?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2016-09. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02952313?
The interventions under investigation include: Nasal Implant (DEVICE).
Who is sponsoring clinical trial NCT02952313?
This trial is sponsored by Spirox, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.